Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists

Kurtzman, Drew J.B.; Vleugels, Ruth Ann

doi:10.1111/bjd.15278

Br J Dermatol

2017

DOI: 10.1111/bjd.15278

|View full text |Cite

Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists

Drew J.B. Kurtzman

Ruth Ann Vleugels

Abstract: Linked Article: Tiao et al. Br J Dermatol 2017; 176:423–430.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Cutaneous Lupus Erythematosus and Dermatomyositis: Utilizing Assessment Tools for Treatment Efficacy

Chong¹,

Werth²

2022

Journal of Investigative Dermatology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists

Abstract: Linked Article: Tiao et al. Br J Dermatol 2017; 176:423–430.

Cited by 4 publications

References 7 publications

Cutaneous Lupus Erythematosus and Dermatomyositis: Utilizing Assessment Tools for Treatment Efficacy

Cutaneous Lupus Erythematosus and Dermatomyositis: Utilizing Assessment Tools for Treatment Efficacy

Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in the Lenabasum Phase 3 Trial

The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review

Contact Info

Product

Resources

About